Cancer and Nanotechnology

Nanotechnology possibly can create selectivity, organic methodologies, and concoction capacity to induce the death of diseased cells while minimizing damage to non-malignant cells. Materials on the Nano scale are slowly oriented by active and passive targeting on cells with exceptional sensitivity to malignant. Chemotherapeutics usually cause damage to the immune system and alternate organs because of their non-specific targeting, lack of solvency, and inability to reach the tumor core resulting in reduced dosage and poor survival care. Nanotechnology helps to identify cancer-related targets rapidly and sensitively, helping scientists to track molecular-level changes even though they exist within a small percentage of cells. In addition, nanotechnology also has the ability to develop novel therapeutic agents which are extremely potential.

 

    Related Conference of Cancer and Nanotechnology

    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Cancer and Nanotechnology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in